11+ hour, 8+ min ago  (8+ words) Bioengineer. org...

20+ hour, 49+ min ago  (76+ words) Technology Networks These epigenetic regulators are chemical tags on the proteins that package DNA. The proteins that recognize these tags determine how the genome is "read" in each cell, activating or deactivating many genes at the same time. "Instead of…...

22+ hour, 49+ min ago  (151+ words) Researchers from IIT Bombay have discovered a promising mechanism that could revolutionize cholesterol treatment. Consequently, this breakthrough offers a safer way to lower blood lipids without triggering fat accumulation in the liver. Q1: What is KTDP and how does it lower…...

19+ hour, 28+ min ago  (405+ words) Scribe Therapeutics announced that it has been awarded more than $25 million from the California Institute for Regenerative Medicine across two preclinical programs targeting cardiovascular and metabolic disease. Scribe is a clinical-stage biotechnology company developing purpose-built in vivo CRISPR technologies designed…...

1+ day, 29+ min ago  (684+ words) A gene therapy designed to replace a missing brain protein restored normal brain activity and improved behavior in a mouse model of Fragile X syndrome (FXS), according to a University of California, Riverside-led study. The findings, published in Molecular Therapy…...

1+ day, 14+ hour ago  (351+ words) Reg Med Net is part of Taylor & Francis Group. Original story from the University of Maryland School of Medicine (UMSOM; MD, USA). Researchers have demonstrated how blocking a specific protein keeps CAR-T cells fighting cancer longer, potentially improving outcomes for…...

1+ day, 31+ min ago  (992+ words) Bio Space Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials - Scribe received multi-year grant awards from the California Institute for Regenerative Medicine (CIRM) to advance two therapeutic…...

1+ day, 9+ hour ago  (312+ words) Spot Biosystems announced its launch from stealth with $40 million in venture financing, along with preclinical research published in Nature Biomedical Engineering and an ongoing first-in-human clinical trial for Duchenne muscular dystrophy. The company is developing a non-viral extracellular vesicle delivery…...

1+ day, 11+ hour ago  (997+ words) CRISPR Medicine News Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials - Scribe received multi-year grant awards from the California Institute for Regenerative Medicine (CIRM) to advance two…...

1+ day, 19+ hour ago  (549+ words) You can therefore only imagine the dread some New York City parents must have felt when, upon entering the metro in the autumn of 2025, they were greeted by a full-height advertisement proclaiming that their little Liam or Olivia had already…...